Defunct Company
Total Trials
6
As Lead Sponsor
3
As Collaborator
Total Enrollment
1,480
NCT03217552
The Performance of the Mologic Biomarker Panel in Infection
Phase: N/A
Role: Lead Sponsor
Start: Nov 26, 2017
Completion: Jul 31, 2019
NCT04297709
Study of Urinary Predictors of Exacerbations by Biomarkers in Cystic Fibrosis
Start: Feb 1, 2018
NCT04070196
Point-of-care Test for Diagnosis of Peritonitis in Peritoneal Dialysis Patients
Role: Collaborator
Start: Sep 25, 2019
Completion: Feb 24, 2024
NCT04296318
COPD Exacerbation Alert System With urinE anaLysis Using the HEADSTART Device
Start: Nov 19, 2019
Completion: Jul 24, 2022
NCT04427280
Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19)
Start: May 26, 2020
Completion: Jun 29, 2021
NCT06624787
Development Of A Rapid Diagnostic Test To Identify Crimean-Congo Haemorrhagic Fever At The Point-Of-Care
Start: Apr 30, 2026
Completion: Sep 30, 2027